Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

IMDELLTRA

TARLATAMAB-DLLE

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview IMDELLTRA is listed in Drugs@FDA under application 761344 (BLA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient TARLATAMAB-DLLE Form and strength INJECTABLE;INJECTION - 10MG Sponsor AMGEN INC Submission history Latest submission status date: 2025-11-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview IMDELLTRA is listed in Drugs@FDA under application 761344 (BLA). Review priority: PRIORITY Marketing status: Prescription Active ingredient TARLATAMAB-DLLE Form and strength INJECTABLE;INJECTION - 10MG Sponsor AMGEN INC Submission history Latest submission status date: 2025-11-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.